固定式左炔诺孕酮宫内缓释剂治疗大子宫腺肌症临床观察

来源 :中国妇幼保健 | 被引量 : 0次 | 上传用户:hzxy05jsjb
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:研究固定式左炔诺孕酮(LNG)宫内缓释剂对大子宫腺肌症的临床疗效。方法:对30例已确诊为子宫腺肌症的妇女放置固定式LNG宫内缓释剂,随访18个月,观察脱环率、带器妊娠率,比较痛经程度、月经量、血红蛋白水平及子宫大小变化情况。结果:配戴患者无脱环和带器妊娠发生,痛经程度明显缓解(P<0.05),月经量减少(P<0.05),血红蛋白水平显著提高(P<0.05),子宫体积呈缩小趋势(P<0.05)。结论:大子宫腺肌症患者放置固定式LNG宫内缓释剂,不易下移脱落,在避孕、缓解痛经及减少经量方面疗效显著,有较好的临床应用价值。 Objective: To study the clinical efficacy of intrauterine sustained release levonorgestrel (LNG) in large adenomyosis. Methods: Thirty patients with diagnosed as adenomyosis were treated with intrauterine sustained release of LNG, and were followed up for 18 months. The rate of decortication, pregnancy rate of the device, degree of dysmenorrhea, menstrual flow, hemoglobin and uterus Size changes. Results: Dysmenorrhea was significantly relieved (P <0.05), menstruation was reduced (P <0.05), hemoglobin level was significantly increased (P <0.05) and uterine volume was decreased (P <0.05). CONCLUSIONS: Large adenosine myopathy patients have fixed LNG intrauterine sustained-release agents, which are not easy to move down and fall off. They are effective in contraception, relieving dysmenorrhea and reducing the amount of menstruation, and have good clinical value.
其他文献
期刊
期刊
期刊
期刊
期刊
期刊
目的:探讨Klotho基因-395 A/G多态性和子痫前期的发病及其严重程度的相关性.方法:采用等位基因特异性多聚酶链反应(AS-PCR)技术以182例患有子痫前期的孕妇(其中轻度子痫前期9
目的:观察国产重组人甲状旁腺素(1-34)〔rhPTH(1-34)〕和口降钙素对绝经后骨质疏松症(PMOP)的疗效和安全性。方法:将57例PMOP患者随机分为试验组和对照组,试验组皮下注射rhPT
目的:探讨脊柱后路手术治疗重度脊柱畸形合并神经功能障碍的疗效。方法回顾性分析14例后路手术治疗重度脊柱畸形合并神经功能障碍患者的临床情况。其中先天性脊柱畸形9例,神经
期刊